The rapid development of nanotechnology across various industries, including medicine, cosmetics, and food products, necessitates a rigorous regulatory framework. The FDA recognized that existing guidelines might not be adequate to address the unique properties and potential risks of nanomaterials, prompting the creation of the task force.
